SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
0.5062
-0.0136 (-2.62%)
At close: Nov 5, 2025, 4:00 PM EST
0.5119
+0.0057 (1.13%)
After-hours: Nov 5, 2025, 4:10 PM EST
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $338.00K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $766.00K. In the year 2024, SeaStar Medical Holding had annual revenue of $135.00K.
Revenue (ttm)
$766.00K
Revenue Growth
n/a
P/S Ratio
4.92
Revenue / Employee
$40,316
Employees
19
Market Cap
17.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 135.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ICU News
- 6 hours ago - SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 - GlobeNewsWire
- 5 weeks ago - SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury - GlobeNewsWire
- 6 weeks ago - SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children - GlobeNewsWire
- 2 months ago - SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival - GlobeNewsWire
- 3 months ago - SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025 - GlobeNewsWire